These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when? Dogansen SC; Selcukbiricik OS; Tanrikulu S; Yarman S Pituitary; 2016 Jun; 19(3):303-10. PubMed ID: 26830552 [TBL] [Abstract][Full Text] [Related]
28. [Cost-effectiveness analysis of two therapeutic methods for prolactinoma]. Zhen JR; Yu Q; Zhang YH; Ma WB; Lin SQ Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):257-61. PubMed ID: 18843964 [TBL] [Abstract][Full Text] [Related]
29. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly. Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360 [TBL] [Abstract][Full Text] [Related]
30. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up]. Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664 [TBL] [Abstract][Full Text] [Related]
31. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up. Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079 [TBL] [Abstract][Full Text] [Related]
32. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874 [TBL] [Abstract][Full Text] [Related]
33. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902 [TBL] [Abstract][Full Text] [Related]
34. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Perrin G; Treluyer C; Trouillas J; Sassolas G; Goutelle A Pathol Res Pract; 1991 Jun; 187(5):587-92. PubMed ID: 1923955 [TBL] [Abstract][Full Text] [Related]
36. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas]. Yokoyama M No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of bromocriptine in the treatment of macroprolactinomas. Essaïs O; Bouguerra R; Hamzaoui J; Marrakchi Z; Hadjri S; Chamakhi S; Zidi B; Ben Slama C Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):524-31. PubMed ID: 12527854 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis and drug therapy of prolactinoma. Ciccarelli E; Camanni F Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617 [TBL] [Abstract][Full Text] [Related]